• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受抗逆转录病毒治疗的患者中免疫抑制和HIV控制与卡波西肉瘤的关联。

The association of immunosuppression and HIV control with Kaposi sarcoma among patients on antiretroviral therapy.

作者信息

Coghill Anna E, Thompson Zachary, Bamford Laura, Burkholder Greer, Enron Joseph, Gopal Satish, Kitahata Mari M, Mayer Kenneth H, Moore Richard, Yendewa George, Dickey Brittney L, Yanik Elizabeth, Achenbach Chad

机构信息

Cancer Epidemiology Program, Division of Population Science, Moffitt Cancer Center.

Biostatistics and Bioinformatics Program, Moffitt Cancer Center.

出版信息

AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004303.

DOI:10.1097/QAD.0000000000004303
PMID:40704994
Abstract

OBJECTIVE

Access to antiretroviral therapy (ART) has resulted in a decline in Kaposi sarcoma (KS) incidence among people with HIV (PWH). However, KS is still occurring among PWH receiving ART, and it is important to understand the degree to which risk of KS is impacted by response to ART.

METHODS

We examined the changing epidemiology of KS among >20,000 PWH receiving HIV care between 1996 and 2016 in the Center for AIDS Research Network of Integrated Clinical Systems (CNICS). We evaluated the association of KS with CD4 count and HIV viral load at ART initiation, within 6-12 months, and during clinical follow-up.

RESULTS

A total of 344 PWH were diagnosed with KS. CD4 count <200 cells/uL at ART initiation was associated with a >6-fold increased KS risk. Likewise, an HIV viral load >50,000 copies/mL at ART initiation was associated with a >3-fold increased KS risk. For every 100 cells/uL increase in CD4 count or log-unit decrease in HIV viral load during the 12-18 months after ART initiation, we observed 11% and 7% lower KS risks, respectively. During clinical follow-up after ART initiation, every 10% increase in time with a CD4 count >350 cells/uL or an HIV viral load <500 copies/mL was associated with 24% and 26% lower KS risks, respectively. All results reported here were statistically significant at the p < 0.05 threshold.

CONCLUSION

KS risk among PWH receiving HIV care was significantly impacted by not only CD4 count and viral load at ART initiation, but also long-term suppression of HIV after ART initiation.

摘要

目的

获得抗逆转录病毒疗法(ART)已导致艾滋病毒感染者(PWH)中卡波西肉瘤(KS)的发病率下降。然而,接受ART的PWH中仍有KS发生,了解ART反应对KS风险的影响程度很重要。

方法

我们在综合临床系统艾滋病研究网络中心(CNICS)研究了1996年至2016年间接受艾滋病毒护理的20000多名PWH中KS流行病学的变化。我们评估了KS与ART开始时、6至12个月内以及临床随访期间的CD4细胞计数和艾滋病毒病毒载量之间的关联。

结果

共有344名PWH被诊断为KS。ART开始时CD4细胞计数<200个/微升与KS风险增加6倍以上相关。同样,ART开始时艾滋病毒病毒载量>50000拷贝/毫升与KS风险增加3倍以上相关。在ART开始后的12至18个月内,CD4细胞计数每增加100个/微升或艾滋病毒病毒载量每降低1个对数单位,我们分别观察到KS风险降低11%和7%。在ART开始后的临床随访期间,CD4细胞计数>350个/微升或艾滋病毒病毒载量<500拷贝/毫升的时间每增加10%,分别与KS风险降低24%和26%相关。此处报告的所有结果在p<0.05阈值时具有统计学意义。

结论

接受艾滋病毒护理的PWH中的KS风险不仅受到ART开始时的CD4细胞计数和病毒载量的显著影响,还受到ART开始后艾滋病毒的长期抑制的显著影响。

相似文献

1
The association of immunosuppression and HIV control with Kaposi sarcoma among patients on antiretroviral therapy.接受抗逆转录病毒治疗的患者中免疫抑制和HIV控制与卡波西肉瘤的关联。
AIDS. 2025 Jul 18. doi: 10.1097/QAD.0000000000004303.
2
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.用于治疗符合抗逆转录病毒治疗条件的孕妇艾滋病毒感染的抗逆转录病毒疗法。
Cochrane Database Syst Rev. 2010 Mar 17(3):CD008440. doi: 10.1002/14651858.CD008440.
3
Plasma Viral Load of 200 Copies/mL is a Suitable Threshold to Define Viral Suppression and HIV Drug Resistance Testing in Low- and Middle-Income Countries: Evidence From a Facility-Based Study in Cameroon.血浆病毒载量200拷贝/毫升是中低收入国家定义病毒抑制和艾滋病毒耐药性检测的合适阈值:来自喀麦隆一项基于机构的研究的证据。
J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241306484. doi: 10.1177/23259582241306484.
4
Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.抗逆转录病毒疗法对2岁以下感染艾滋病毒儿童的疗效。
Cochrane Database Syst Rev. 2012 Jul 11(7):CD004772. doi: 10.1002/14651858.CD004772.pub3.
5
Optimal time for initiation of antiretroviral therapy in asymptomatic, HIV-infected, treatment-naive adults.无症状、初治的HIV感染成年患者开始抗逆转录病毒治疗的最佳时机。
Cochrane Database Syst Rev. 2010 Mar 17;2010(3):CD008272. doi: 10.1002/14651858.CD008272.pub2.
6
Spectrum and trends of cancer among HIV patients in Southwestern Uganda.乌干达西南部HIV患者的癌症谱及趋势
PLoS One. 2025 Jan 27;20(1):e0317222. doi: 10.1371/journal.pone.0317222. eCollection 2025.
7
Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults.成人慢性未抑制的HIV感染中的结构化治疗中断(STI)
Cochrane Database Syst Rev. 2006 Jul 19;2006(3):CD006148. doi: 10.1002/14651858.CD006148.
8
Indicators for Increased Likelihood of Epidemic Kaposi Sarcoma Progression After Antiretroviral Therapy Initiation.抗逆转录病毒治疗开始后流行性卡波西肉瘤进展可能性增加的指标。
AIDS Res Hum Retroviruses. 2025 Jul;41(7):348-356. doi: 10.1089/aid.2025.0007. Epub 2025 Apr 3.
9
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial.在未接受过抗逆转录病毒治疗的HIV感染者中,同时启动基于多替拉韦的抗逆转录病毒疗法以及每周一次的利福喷汀和异烟肼用于预防结核病:一项开放标签、非随机的1/2期试验。
Lancet HIV. 2025 Jun;12(6):e428-e439. doi: 10.1016/S2352-3018(25)00002-5. Epub 2025 May 8.
10
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.用于降低艾滋病毒感染母婴传播风险的抗逆转录病毒药物。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD003510. doi: 10.1002/14651858.CD003510.pub3.